Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease

Neurobiology of Disease

Volumn 94, Issue , 2016, Pages 32-43

  Ando, Kunie ^a,b,c   Tomimura, Karen ^a,b   Sazdovitch, Véronique ^a   Suain, Valérie ^c   Yilmaz, Zehra ^c   Authelet, Michèle ^c   Ndjim, Marième ^b   Vergara, Cristina ^c   Belkouch, Mounir ^a,b   Potier, Marie Claude ^b   Duyckaerts, Charles ^a,b   Brion, Jean Pierre ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Alzheimer's disease; Autophagy; Beclin 1; Corticobasal degeneration; Diffuse Lewy body disease; FTLD MAPT; FTLD TDP; LC3; NFTs; PICALM; Pick disease; Progressive supranuclear palsy; Tau

Indexed keywords

ADAPTOR PROTEIN; BECLIN 1; LC3 PROTEIN; MARKER; PHOSPHATIDYLINOSITOL BINDING CLATHRIN ASSEMBLY PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG; AUTOPHAGY RELATED PROTEIN; CLATHRIN; CLATHRIN ASSEMBLY PROTEIN; PICALM PROTEIN, HUMAN;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; ASTROCYTE; AUTOPHAGY; CELL INCLUSION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DIFFUSE LEWY BODY DISEASE; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLE; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN PHOSPHORYLATION; TAUOPATHY; VERY ELDERLY; BRAIN; ENDOCYTOSIS; METABOLISM; NERVE CELL; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PNEUMOTHORAX;

ALZHEIMER DISEASE; AUTOPHAGY-RELATED PROTEINS; BRAIN; CLATHRIN; ENDOCYTOSIS; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; MONOMERIC CLATHRIN ASSEMBLY PROTEINS; NEUROFIBRILLARY TANGLES; NEURONS; PHOSPHORYLATION; PICK DISEASE OF THE BRAIN; PNEUMOTHORAX; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS; TAUOPATHIES;

EID: 84973879571     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2016.05.017     Document Type: Article

References (59)

1. Adamec E., Mohan P., Vonsattel J.P., Nixon R.A. Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2. Acta Neuropathol. 2002, 104(1):92-104.
2. Ando K., Leroy K., Heraud C., Yilmaz Z., Authelet M., Suain V., et al. Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model. Am. J. Pathol. 2011, 178(2):803-816.
3. Ando K., Brion J.P., Stygelbout V., Suain V., Authelet M., Dedecker R., et al. Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains. Acta Neuropathol. 2013, 125(6):861-878.
4. Arai T., Ikeda K., Akiyama H., Nonaka T., Hasegawa M., Ishiguro K., et al. Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann. Neurol. 2004, 55(1):72-79.
5. Baig S., Joseph S.A., Tayler H., Abraham R., Owen M.J., Williams J., et al. Distribution and expression of picalm in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2010, 69(10):1071-1077.
6. Boland B., Kumar A., Lee S., Platt F.M., Wegiel J., Yu W.H., et al. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J. Neurosci. 2008, 28(27):6926-6937.
7. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82(4):239-259.
8. Brandt R., Leger J., Lee G. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell Biol. 1995, 131(5):1327-1340.
9. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 2000, 33(1):95-130.
10. Bushlin I., Petralia R.S., Wu F., Harel A., Mughal M.R., Mattson M.P., et al. Clathrin assembly protein AP180 and CALM differentially control axogenesis and dendrite outgrowth in embryonic hippocampal neurons. J. Neurosci. 2008, 28(41):10257-10271.
11. Chapuis J., Hansmannel F., Gistelinck M., Mounier A., Van Cauwenberghe C., Kolen K.V., et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol. Psychiatry 2013, 18(11):1225-1234.
12. Clavaguera F., Akatsu H., Fraser G., Crowther R.A., Frank S., Hench J., et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(23):9535-9540.
13. Coleman P.D., Yao P.J. Synaptic slaughter in Alzheimer's disease. Neurobiol. Aging 2003, 24(8):1023-1027.
14. Dickson D.W., Rademakers R., Hutton M.L. Progressive supranuclear palsy: pathology and genetics. Brain Pathol. 2007, 17(1):74-82.
15. Duyckaerts C., Delatour B., Potier M.C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009, 118(1):5-36.
16. Farrer L.A., Abraham C.R., Volicer L., Foley E.J., Kowall N.W., McKee A.C., et al. Allele epsilon 4 of apolipoprotein E shows a dose effect on age at onset of pick disease. Exp. Neurol. 1995, 136(2):162-170.
17. Feany M.B., Dickson D.W. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann. Neurol. 1996, 40(2):139-148.
18. Ford M.G., Pearse B.M., Higgins M.K., Vallis Y., Owen D.J., Gibson A., et al. Simultaneous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science (New York. NY 2001, 291(5506):1051-1055.
19. Goedert M., Jakes R., Spillantini M.G., Hasegawa M., Smith M.J., Crowther R.A. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 1996, 383(6600):550-553.
20. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 2009, 41(10):1088-1093.
21. Hayashi S., Wakabayashi K., Iwanaga K., Kakita A., Seki K., Tanaka M., et al. Pick's disease: selective occurrence of apolipoprotein E-immunoreactive pick bodies in the limbic system. Acta Neuropathol. 1998, 95(1):1-4.
22. Huang Y., Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell 2012, 148(6):1204-1222.
23. Huang Y., Liu X.Q., Wyss-Coray T., Brecht W.J., Sanan D.A., Mahley R.W. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(15):8838-8843.
24. Kim J.A., Kim H.L. Cleavage of purified neuronal clathrin assembly protein (CALM) by caspase 3 and calpain. Exp. Mol. Med. 2001, 33(4):245-250.
25. Klionsky D.J., Abdelmohsen K., Abe A., Abedin M.J., Abeliovich H., Acevedo Arozena A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 2016, 12(1):1-222.
26. Kovacs G.G. Invited review: neuropathology of tauopathies: principles and practice. Neuropathol. Appl. Neurobiol. 2015, 41(1):3-23.
27. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 2009, 41(10):1094-1099.
28. Lambert J.C., Ibrahim-Verbaas C.A., Harold D., Naj A.C., Sims R., Bellenguez C., et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 2013, 45(12):1452-1458.
29. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 2001, 24:1121-1159.
30. Mackenzie I.R., Neumann M., Bigio E.H., Cairns N.J., Alafuzoff I., Kril J., et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol. 2009, 117(1):15-18.
31. Moreau K., Fleming A., Imarisio S., Lopez Ramirez A., Mercer J.L., Jimenez-Sanchez M., et al. PICALM modulates autophagy activity and tau accumulation. Nat. Commun. 2014, 5:4998.
32. Morgen K., Ramirez A., Frolich L., Tost H., Plichta M.M., Kolsch H., et al. Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease. Alzheim. Dementia: J. Alzheim. Assoc 2014, 10(5 Suppl):S269-S276.
33. Naj A.C., Jun G., Beecham G.W., Wang L.S., Vardarajan B.N., Buros J., et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 2011, 43(5):436-441.
34. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314(5796):130-133. New York, NY.
35. Nishikawa T., Takahashi T., Nakamori M., Yamazaki Y., Kurashige T., Nagano Y., et al. Phosphatidylinositol-4,5-bisphosphate is enriched in granulovacuolar degeneration bodies and neurofibrillary tangles. Neuropathol. Appl. Neurobiol. 2014, 40(4):489-501.
36. Nixon R.A. Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases. Neurobiol. Aging 2005, 26(3):373-382.
37. Nixon R.A. The role of autophagy in neurodegenerative disease. Nat. Med. 2013, 19(8):983-997.
38. Nixon R.A., Yang D.S. Autophagy failure in Alzheimer's disease-locating the primary defect. Neurobiol. Dis. 2011, 43(1):38-45.
39. Pickford F., Masliah E., Britschgi M., Lucin K., Narasimhan R., Jaeger P.A., et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest. 2008, 118(6):2190-2199.
40. Rohn T.T., Catlin L.W., Coonse K.G., Habig J.W. Identification of an amino-terminal fragment of apolipoprotein E4 that localizes to neurofibrillary tangles of the Alzheimer's disease brain. Brain Res. 2012, 1475:106-115.
41. Rohn T.T., Day R.J., Catlin L.W., Brown R.J., Rajic A.J., Poon W.W. Immunolocalization of an amino-terminal fragment of apolipoprotein E in the Pick's disease brain. PLoS One 2013, 8(12).
42. Rudinskiy N., Grishchuk Y., Vaslin A., Puyal J., Delacourte A., Hirling H., et al. Calpain hydrolysis of alpha- and beta2-adaptins decreases clathrin-dependent endocytosis and may promote neurodegeneration. J. Biol. Chem. 2009, 284(18):12447-12458.
43. Saha A.R., Ninkina N.N., Hanger D.P., Anderton B.H., Davies A.M., Buchman V.L. Induction of neuronal death by alpha-synuclein. Eur. J. Neurosci. 2000, 12(8):3073-3077.
44. Saito K., Elce J.S., Hamos J.E., Nixon R.A. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. U. S. A. 1993, 90(7):2628-2632.
45. Sanders D.W., Kaufman S.K., DeVos S.L., Sharma A.M., Mirbaha H., Li A., et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 2014, 82(6):1271-1288.
46. Sergeant N., Wattez A., Delacourte A. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms. J. Neurochem. 1999, 72(3):1243-1249.
47. Seshadri S., Fitzpatrick A.L., Ikram M.A., DeStefano A.L., Gudnason V., Boada M., et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010, 303(18):1832-1840.
48. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388(6645):839-840.
49. Spillantini M.G., Crowther R.A., Kamphorst W., Heutink P., van Swieten J.C. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. Am. J. Pathol. 1998, 153(5):1359-1363.
50. Thal D.R., Rub U., Orantes M., Braak H. Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58(12):1791-1800.
51. Tian Y., Chang J.C., Fan E.Y., Flajolet M., Greengard P. Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(42):17071-17076.
52. Tian Y., Chang J.C., Greengard P., Flajolet M. The convergence of endosomal and autophagosomal pathways: implications for APP-CTF degradation. Autophagy 2014, 10(4):694-696.
53. Tracz E., Dickson D.W., Hainfeld J.F., Ksiezak-Reding H. Paired helical filaments in corticobasal degeneration: the fine fibrillary structure with NanoVan. Brain Res. 1997, 773(1-2):33-44.
54. Uchihara T. Pretangles and neurofibrillary changes: similarities and differences between AD and CBD based on molecular and morphological evolution. Neuropathology 2014, 34(6):571-577.
55. Wang Y., Mandelkow E. Tau in physiology and pathology. Nat. Rev. Neurosci. 2016, 17(1):22-35.
56. Yao P.J. Synaptic frailty and clathrin-mediated synaptic vesicle trafficking in Alzheimer's disease. Trends Neurosci. 2004, 27(1):24-29.
57. Yoshida M. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration. Neuropathol.: Off. J. Japan. Soc. Neuropathol. 2014, 34(6):555-570.
58. Zhao Z., Sagare A.P., Ma Q., Halliday M.R., Kong P., Kisler K., et al. Central role for PICALM in amyloid-beta blood-brain barrier transcytosis and clearance. Nat. Neurosci. 2015, 18(7):978-987.
59. Zhou Y., Hayashi I., Wong J., Tugusheva K., Renger J.J., Zerbinatti C. Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein tau in Alzheimer's disease. PLoS One 2014, 9(7).